Medico Remedies Limited (NSE:MEDICO)

Market Cap	3.22B
Revenue (ttm)	1.58B
Net Income (ttm)	103.33M
Shares Out	n/a
EPS (ttm)	1.25
PE Ratio	31.16
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,706
Average Volume	189,693
Open	39.30
Previous Close	38.93
Day's Range	38.65 - 39.30
52-Week Range	37.18 - 79.83
Beta	0.03
RSI	45.23
Earnings Date	Nov 14, 2025

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In 2024, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.